Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hormone-refractory prostate cancer
ADR ID BADD_A08652
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.25      Reproductive neoplasms male malignant and unspecified
16.25.01      Prostatic neoplasms malignant
16.25.01.004      Hormone-refractory prostate cancer
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.02      Prostatic neoplasms and hypertrophy
21.04.02.007      Hormone-refractory prostate cancer
Description Not Available
MedDRA Code 10062904
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Hormone-refractory prostate cancer | Castration-resistant prostate cancer | Hormone-refractory prostate cancer metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone--
BADD_D00271Bicalutamide0.001406%
BADD_D00364Carboplatin0.000168%
BADD_D00775Enzalutamide0.003570%
BADD_D01260Leuprolide acetate0.006453%
BADD_D02490Apalutamide--
BADD_D02548Darolutamide0.006173%
BADD_D02567Lutetium lu-177 vipivotide tetraxetan-
BADD_D02586Radium ra-223 dichloride-
The 1th Page    1    Total 1 Pages